Published on in Vol 6, No 12 (2017): December

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/8907, first published .
The Second-Look Procedure for Transoral Videolaryngoscopic Surgery for T1 and T2 Laryngeal, Oropharyngeal, and Hypopharyngeal Cancer Patients: Protocol for a Nonrandomized Clinical Trial

The Second-Look Procedure for Transoral Videolaryngoscopic Surgery for T1 and T2 Laryngeal, Oropharyngeal, and Hypopharyngeal Cancer Patients: Protocol for a Nonrandomized Clinical Trial

The Second-Look Procedure for Transoral Videolaryngoscopic Surgery for T1 and T2 Laryngeal, Oropharyngeal, and Hypopharyngeal Cancer Patients: Protocol for a Nonrandomized Clinical Trial

Journals

  1. Nishimura G, Sano D, Arai Y, Hatano T, Takahashi H, Tanabe T, Wada T, Morishita D, Oridate N. A prospective clinical trial of the second‐look procedure for transoral surgery in patients with T1 and T2 laryngeal, oropharyngeal, and hypopharyngeal cancer. Cancer Medicine 2019;8(17):7197 View
  2. Nishimura G, Sano D, Arai Y, Hatano T, Takahashi H, Kitani Y, Takada K, Wada T, Oridate N. The incidence of newly diagnosed secondary cancer; sub-analysis the prospective study of the second-look procedure for transoral surgery in patients with T1 and T2 head and neck cancer. International Journal of Clinical Oncology 2021;26(1):59 View
  3. Nishimura G, Sano D, Arai Y, Takahashi H, Hatano T, Kitani Y, Takada K, Wada T, Hiiragi Y, Oridate N. Validation of the risk factors for primary control of early T-stage laryngeal, oropharyngeal, and hypopharyngeal squamous cell carcinoma by transoral surgery: a prospective observational study. International Journal of Clinical Oncology 2021;26(11):1995 View
  4. Nishimura G, Sano D, Arai Y, Takahashi H, Hatano T, Kitani Y, Takada K, Wada T, Hiiragi Y, Oridate N. A risk factor for newly diagnosed secondary cancer in patients with early-stage laryngeal, oropharyngeal, or hypopharyngeal cancer: sub-analysis of a prospective observation study. International Journal of Clinical Oncology 2022;27(3):488 View